Single-use Bioreactors Market Size to Attain USD 33.70 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Single-use Bioreactors Market, By Product

7.1. Single-use Bioreactors Market, by Product

7.1.1. Single-use Bioreactor Systems

7.1.1.1. Market Revenue and Forecast

7.1.2. Single-use Media Bags

7.1.2.1. Market Revenue and Forecast

7.1.3. Single-use Filtration Assemblies

7.1.3.1. Market Revenue and Forecast

7.1.4. Other Products

7.1.4.1. Market Revenue and Forecast

Chapter 8. Global Single-use Bioreactors Market, By Type

8.1. Single-use Bioreactors Market, by Type

8.1.1. Stirred-tank SUBs

8.1.1.1. Market Revenue and Forecast

8.1.2. Bubble-column SUBs

8.1.2.1. Market Revenue and Forecast

8.1.3. Wave-induced SUBs

8.1.3.1. Market Revenue and Forecast

8.1.4. Other SUBs

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Single-use Bioreactors Market, By Type of Cell

9.1. Single-use Bioreactors Market, by Type of Cell

9.1.1. Mammalian Cells

9.1.1.1. Market Revenue and Forecast

9.1.2. Yeast Cells

9.1.2.1. Market Revenue and Forecast

9.1.3. Bacterial Cells

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Single-use Bioreactors Market, By Molecule Type

10.1. Single-use Bioreactors Market, by Molecule Type

10.1.1. Monoclonal Antibodies

10.1.1.1. Market Revenue and Forecast

10.1.2. Vaccines

10.1.2.1. Market Revenue and Forecast

10.1.3. Stem Cells

10.1.3.1. Market Revenue and Forecast

10.1.4. Gene Modified Cells

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Single-use Bioreactors Market, By Application

11.1. Single-use Bioreactors Market, by Application

11.1.1. Research and Development (R&D) or Process Development

11.1.1.1. Market Revenue and Forecast

11.1.2. Bioproduction

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Single-use Bioreactors Market, By End-Use

12.1. Single-use Bioreactors Market, by End-Use

12.1.1. CROs & CMOs

12.1.1.1. Market Revenue and Forecast

12.1.2. Pharmaceutical & Biopharmaceutical Companies

12.1.2.1. Market Revenue and Forecast

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Single-use Bioreactors Market, By Usage Type

13.1. Single-use Bioreactors Market, by Usage Type

13.1.1. Pilot-scale Production

13.1.1.1. Market Revenue and Forecast

13.1.2. Lab-scale Production

13.1.2.1. Market Revenue and Forecast

13.1.3. Large-scale Production

13.1.3.1. Market Revenue and Forecast

Chapter 14. Global Single-use Bioreactors Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product

14.1.2. Market Revenue and Forecast, by Type

14.1.3. Market Revenue and Forecast, by Type of Cell

14.1.4. Market Revenue and Forecast, by Molecule Type

14.1.5. Market Revenue and Forecast, by Application

14.1.6. Market Revenue and Forecast, by Usage Type

14.1.7. Market Revenue and Forecast, by End-Use

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Product

14.1.8.2. Market Revenue and Forecast, by Type

14.1.8.3. Market Revenue and Forecast, by Type of Cell

14.1.8.4. Market Revenue and Forecast, by Molecule Type

14.1.8.5. Market Revenue and Forecast, by Application

14.1.8.6. Market Revenue and Forecast, by Usage Type

14.1.8.7. Market Revenue and Forecast, by End-Use

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product

14.1.9.2. Market Revenue and Forecast, by Type

14.1.9.3. Market Revenue and Forecast, by Type of Cell

14.1.9.4. Market Revenue and Forecast, by Molecule Type

14.1.9.5. Market Revenue and Forecast, by Application

14.1.9.6. Market Revenue and Forecast, by Usage Type

14.1.9.7. Market Revenue and Forecast, by End-Use

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product

14.2.2. Market Revenue and Forecast, by Type

14.2.3. Market Revenue and Forecast, by Type of Cell

14.2.4. Market Revenue and Forecast, by Molecule Type

14.2.5. Market Revenue and Forecast, by Application

14.2.6. Market Revenue and Forecast, by Usage Type

14.2.7. Market Revenue and Forecast, by End-Use

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product

14.2.8.2. Market Revenue and Forecast, by Type

14.2.8.3. Market Revenue and Forecast, by Type of Cell

14.2.8.4. Market Revenue and Forecast, by Molecule Type

14.2.8.5. Market Revenue and Forecast, by Application

14.2.8.6. Market Revenue and Forecast, by Usage Type

14.2.8.7. Market Revenue and Forecast, by End-Use

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Product

14.2.9.2. Market Revenue and Forecast, by Type

14.2.9.3. Market Revenue and Forecast, by Type of Cell

14.2.9.4. Market Revenue and Forecast, by Molecule Type

14.2.9.5. Market Revenue and Forecast, by Application

14.2.9.6. Market Revenue and Forecast, by Usage Type

14.2.9.7. Market Revenue and Forecast, by End-Use

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Product

14.2.10.2. Market Revenue and Forecast, by Type

14.2.10.3. Market Revenue and Forecast, by Type of Cell

14.2.10.4. Market Revenue and Forecast, by Molecule Type

14.2.10.5. Market Revenue and Forecast, by Application

14.2.10.6. Market Revenue and Forecast, by Usage Type

14.2.10.7. Market Revenue and Forecast, by End-Use

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Product

14.2.11.2. Market Revenue and Forecast, by Type

14.2.11.3. Market Revenue and Forecast, by Type of Cell

14.2.11.4. Market Revenue and Forecast, by Molecule Type

14.2.11.5. Market Revenue and Forecast, by Application

14.2.11.6. Market Revenue and Forecast, by Usage Type

14.2.11.7. Market Revenue and Forecast, by End-Use

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product

14.3.2. Market Revenue and Forecast, by Type

14.3.3. Market Revenue and Forecast, by Type of Cell

14.3.4. Market Revenue and Forecast, by Molecule Type

14.3.5. Market Revenue and Forecast, by Application

14.3.6. Market Revenue and Forecast, by Usage Type

14.3.7. Market Revenue and Forecast, by End-Use

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Product

14.3.8.2. Market Revenue and Forecast, by Type

14.3.8.3. Market Revenue and Forecast, by Type of Cell

14.3.8.4. Market Revenue and Forecast, by Molecule Type

14.3.8.5. Market Revenue and Forecast, by Application

14.3.8.6. Market Revenue and Forecast, by Usage Type

14.3.8.7. Market Revenue and Forecast, by End-Use

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Product

14.3.9.2. Market Revenue and Forecast, by Type

14.3.9.3. Market Revenue and Forecast, by Type of Cell

14.3.9.4. Market Revenue and Forecast, by Molecule Type

14.3.9.5. Market Revenue and Forecast, by Application

14.3.9.6. Market Revenue and Forecast, by Usage Type

14.3.9.7. Market Revenue and Forecast, by End-Use

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Product

14.3.10.2. Market Revenue and Forecast, by Type

14.3.10.3. Market Revenue and Forecast, by Type of Cell

14.3.10.4. Market Revenue and Forecast, by Molecule Type

14.3.10.5. Market Revenue and Forecast, by Application

14.3.10.6. Market Revenue and Forecast, by Usage Type

14.3.10.7. Market Revenue and Forecast, by End-Use

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Product

14.3.11.2. Market Revenue and Forecast, by Type

14.3.11.3. Market Revenue and Forecast, by Type of Cell

14.3.11.4. Market Revenue and Forecast, by Molecule Type

14.3.11.5. Market Revenue and Forecast, by Application

14.3.11.6. Market Revenue and Forecast, by Usage Type

14.3.11.7. Market Revenue and Forecast, by End-Use

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product

14.4.2. Market Revenue and Forecast, by Type

14.4.3. Market Revenue and Forecast, by Type of Cell

14.4.4. Market Revenue and Forecast, by Molecule Type

14.4.5. Market Revenue and Forecast, by Application

14.4.6. Market Revenue and Forecast, by Usage Type

14.4.7. Market Revenue and Forecast, by End-Use

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Product

14.4.8.2. Market Revenue and Forecast, by Type

14.4.8.3. Market Revenue and Forecast, by Type of Cell

14.4.8.4. Market Revenue and Forecast, by Molecule Type

14.4.8.5. Market Revenue and Forecast, by Application

14.4.8.6. Market Revenue and Forecast, by Usage Type

14.4.8.7. Market Revenue and Forecast, by End-Use

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Product

14.4.9.2. Market Revenue and Forecast, by Type

14.4.9.3. Market Revenue and Forecast, by Type of Cell

14.4.9.4. Market Revenue and Forecast, by Molecule Type

14.4.9.5. Market Revenue and Forecast, by Application

14.4.9.6. Market Revenue and Forecast, by Usage Type

14.4.9.7. Market Revenue and Forecast, by End-Use

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Product

14.4.10.2. Market Revenue and Forecast, by Type

14.4.10.3. Market Revenue and Forecast, by Type of Cell

14.4.10.4. Market Revenue and Forecast, by Molecule Type

14.4.10.5. Market Revenue and Forecast, by Application

14.4.10.6. Market Revenue and Forecast, by Usage Type

14.4.10.7. Market Revenue and Forecast, by End-Use

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Product

14.4.11.2. Market Revenue and Forecast, by Type

14.4.11.3. Market Revenue and Forecast, by Type of Cell

14.4.11.4. Market Revenue and Forecast, by Molecule Type

14.4.11.5. Market Revenue and Forecast, by Application

14.4.11.6. Market Revenue and Forecast, by Usage Type

14.4.11.7. Market Revenue and Forecast, by End-Use

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product

14.5.2. Market Revenue and Forecast, by Type

14.5.3. Market Revenue and Forecast, by Type of Cell

14.5.4. Market Revenue and Forecast, by Molecule Type

14.5.5. Market Revenue and Forecast, by Application

14.5.6. Market Revenue and Forecast, by Usage Type

14.5.7. Market Revenue and Forecast, by End-Use

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Product

14.5.8.2. Market Revenue and Forecast, by Type

14.5.8.3. Market Revenue and Forecast, by Type of Cell

14.5.8.4. Market Revenue and Forecast, by Molecule Type

14.5.8.5. Market Revenue and Forecast, by Application

14.5.8.6. Market Revenue and Forecast, by Usage Type

14.5.8.7. Market Revenue and Forecast, by End-Use

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product

14.5.9.2. Market Revenue and Forecast, by Type

14.5.9.3. Market Revenue and Forecast, by Type of Cell

14.5.9.4. Market Revenue and Forecast, by Molecule Type

14.5.9.5. Market Revenue and Forecast, by Application

14.5.9.6. Market Revenue and Forecast, by Usage Type

14.5.9.7. Market Revenue and Forecast, by End-Use

Chapter 15. Company Profiles

15.1. ABEC Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Able Corporation & Biott Corporation (Japan)

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Applikon Biotechnology B.V.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Aptus bioreactors.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5 Cell culture company

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Cellexus Ltd

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Celltainer Biotech BV (Netherlands)

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. CESCO Bioengineering Co., Ltd.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Danaher Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Distek Inc. (US)

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global single-use bioreactors market size was accounted at USD 6.12 billion in 2024 and is projected to hit around USD 33.70 billion by 2034.

The global single-use bioreactors market is poised to grow at a CAGR of 18.60% from 2025 to 2034.

The major players operating in the single-use bioreactors market are ABEC Inc., Able Corporation & Biott Corporation, Applikon Biotechnology B.V., Aptus bioreactors., Cell culture company, Cellexus Ltd, Celltainer Biotech BV, CESCO Bioengineering Co., Ltd., Danaher Corporation, Distek Inc., ENDEL ENGIE, Eppendorf AG, G&G Technologies Inc., GE Healthcare, Getinge AB, GPC Bio, Infors AG., Meissner Filtration Products Inc., Merck KgaA, New Horizon Biotechnology Inc., OmniBRx Biotechnologies, Pall Corporation and Others

Rising R&D spending on biopharmaceuticals and increasing elderly population's increased susceptibility to a variety of diseases, these are driving factors of the single-use bioreactors market.

North America region will lead the global single-use bioreactors market during the forecast period 2025 to 2034.